A study conducted by Boston University scientists on over 5,000 adults throughout their lives, suggests that having high cholesterol levels in your thirties could raise your risk of Alzheimer’s later in life.
Dr Lindsay Farrer, of the Boston University School of Medicine, added: ‘Intervention targeting cholesterol and glucose management starting in early adulthood can help maximize cognitive health in later life.’
DirectorsTalk asked Goodbody Health CEO Marc Howells about the importance of regular blood testing:
Marc said: “There is now a wealth of scientific evidence that high cholesterol clogs your arteries and causes cardiovascular disease over time. The British Heart Foundation estimate 7.6 million people in the UK are living with heart and circulatory diseases which results in a death every 3 minutes. The good news is that it is entirely preventable so long as you take regular blood tests, make health lifestyle changes and seek out treatments if needed.
Goodbody Health’s motto is ‘Know More, Live Better’. We believe individuals should be able to take control of their own health – that’s why Goodbody is now offering over 30 blood and PCR tests for at home or in-clinic testing for peace of mind. It’s amazing that we MOT our cars every year but most people don’t think of having a blood MOT. Goodbody Health is on a mission to raise awareness and educate people of the importance of monitoring and managing their health. There is currently no way to cure Alzheimer’s and most people don’t know they have high cholesterol because it doesn’t usually have any symptoms. I therefore highly recommend everyone has a cholesterol check as part of a regular ‘MOT’ of their blood.”
The Goodbody Health Group Inc. is listed on the Canadian Securities Exchange (CSE), the Aquis Stock Exchange – Growth Market (AQSE) Apex segment, OTC Pink, and Frankfurt Stock Exchange (FSE), providing current and prospective shareholders with multiple platforms in which to buy and sell Goodbody Health Group Inc. stock under the EPIC codes: CSE: GDBY / AQSE: GDBY / FRA: 484 / OTC: GDBYF).
